Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort

BACKGROUND: Major Depressive Disorder (MDD) is among the most prevalent and disabling medical conditions worldwide. Identification of clinical and biological markers (“biomarkers”) of treatment response could personalize clinical decisions and lead to better outcomes. This paper describes the aims,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Raymond W., Milev, Roumen, Rotzinger, Susan, Andreazza, Ana C., Blier, Pierre, Brenner, Colleen, Daskalakis, Zafiris J., Dharsee, Moyez, Downar, Jonathan, Evans, Kenneth R., Farzan, Faranak, Foster, Jane A., Frey, Benicio N., Geraci, Joseph, Giacobbe, Peter, Feilotter, Harriet E., Hall, Geoffrey B., Harkness, Kate L., Hassel, Stefanie, Ismail, Zahinoor, Leri, Francesco, Liotti, Mario, MacQueen, Glenda M., McAndrews, Mary Pat, Minuzzi, Luciano, Müller, Daniel J., Parikh, Sagar V., Placenza, Franca M., Quilty, Lena C., Ravindran, Arun V., Salomons, Tim V., Soares, Claudio N., Strother, Stephen C., Turecki, Gustavo, Vaccarino, Anthony L., Vila-Rodriguez, Fidel, Kennedy, Sidney H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833905/
https://www.ncbi.nlm.nih.gov/pubmed/27084692
http://dx.doi.org/10.1186/s12888-016-0785-x

Ejemplares similares

Ejemplares similares